Introduction SARS-CoV-2, responsible for COVID-19, is a pandemic that has taken the world by storm We present the only contemporary reported case of COVID-19 myocarditis leading to recovery with utilization of biventricular impella for temporary mechanical circulatory support No cases have been reported regarding utilization of Bi-V impella as therapy for management of SARS-CoV-2 Case Report We present a 35 year old-woman with history of systemic sclerosis who was found to have 5 days of generalized malaise associated with fevers and cough On arrival she was found tachycardic at 112 bpm and febrile 101 8 F She tested positive for COVID-19 via nasal CPR Cardiac enzymes were found elevated on admission with troponin T elevated at 0 28 On day two of hospitalization patient had spontaneous PEA arrest secondary to hypoxemia Transthoracic echocardiogram(TTE) revealed EF &lt;10% and RV impairment which compare to prior which had normal ejection fraction Labs showed elevated lactic acidosis of 10 Invasive hemodynamics assessment RA 21 mmHg, PA 32/23(mean 26 mmHg) and PCWP 18 mmHg Calculated PAPi 0 76, CO 2 1 L/min and CI of 1 2 L/min/m
The First Reported Case of COVID-19 Myocarditis Managed with Biventricular Impella Support